Louisiana Department of Insurance, orders PBMs and insurers in the state to bring their reimbursement formulas in line with a ...

A Baton Rouge judge allowed Louisiana Insurance Commissioner Tim Temple’s pharmacy reimbursement directive to take effect, ...

If you've been relying on Express Scripts for your 90-day refills and home delivery, 2026 brings a critical shift: a new 'Copay Assurance' program that caps out-of-pocket costs, paired with stricter ...

The CBSE introduced a new On-Screen Marking system, replacing the practice of physically checking answer books.

JOHNSTOWN, Pa. (WTAJ) — Thousands of patients are still separated from a community pharmacy chain in Cambria, Somerset and Westmoreland counties after a 2025 decision by a global health company left ...

Express Scripts agreed to pay a $1.5 million administrative penalty and implement corrective actions following an investigation by the West Virginia Offices of the Insurance Commissioner. Between May ...

For respondents facing novel Federal Trade Commission theories, the lesson is that early engagement—not reflexive litigation—can yield outcomes that address regulatory concerns while preserving ...

Nation’s largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates from PBM customers. NEW YORK--(BUSINESS WIRE)--Today, Bernstein Litowitz Berger & ...

Nation’s largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates from PBM customers. Today, Bernstein Litowitz Berger & Grossmann LLP (BLB&G) ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...